MPNST
Clinical trials for MPNST explained in plain language.
Never miss a new study
Get alerted when new MPNST trials appear
Sign up with your email to follow new studies for MPNST, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for rare nerve cancer: targeted drug trial launches
Disease control Not yet recruitingThis study tests a new medicine, BMS-986504, in people with a rare nerve cancer called MPNST that cannot be removed by surgery. Only patients whose tumors have a specific gene change (MTAP deletion) can join. The goal is to see if the drug can shrink tumors and help control the d…
Matched conditions: MPNST
Phase: PHASE1, PHASE2 • Sponsor: Ankit Mangla, MD • Aim: Disease control
Last updated May 14, 2026 12:06 UTC
-
New drug cocktail shows promise for rare, aggressive sarcomas
Disease control Not yet recruitingThis study tests a combination of three drugs (selumetinib, ZEN-3694, and durvalumab) in people with advanced sarcomas, including a rare nerve tumor called MPNST. The goal is to see if the combination is safe and can shrink tumors or stop them from growing. About 41 adults with s…
Matched conditions: MPNST
Phase: PHASE2 • Sponsor: University of Alabama at Birmingham • Aim: Disease control
Last updated May 07, 2026 18:43 UTC